A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Rezpegaldesleukin
Related studies linked through entity extraction aliases.
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Status
- RECRUITING
- Phase
- PHASE3
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2